#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired haemophilia Behcet's syndrome Antisynthetase syndrome Immunodeficiency common variable Angiosarcoma Allogenic stem cell transplantation Leukocyte adhesion deficiency type I Ataxia telangiectasia VEXAS syndrome Angiosarcoma non-metastatic Diabetes insipidus Peritoneal mesothelioma malignant Fontan procedure Non-small cell lung cancer recurrent Lupus nephritis More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Treatment Sarcoma – Treatment Sarcoidosis – Life with Disease Pelizaeus-Merzbacher disease – Life with Disease Mantle cell lymphoma refractory – Trials in Disease Paraneoplastic neurological syndrome – Diagnostics Uterine leiomyosarcoma – Basic Information Rhabdomyosarcoma recurrent Mucopolysaccharidosis II – Life with Disease Glomerulonephritis membranoproliferative – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dinoprostone Fingolimod Hydrochloride Pemafibrate Neflamapimod Encaleret Sulfate Sulodexide GSKVX000000034798 Sodium Nitroprusside Dihydrate Mk-1088 GSK3862995B Setrusumab [18F]Mc225 Modafinil Alrefimotide Calcium Pantothenate Bp Nomegestrol Acetate Nmd670 GSKVX000000034794 Candesartan Icosapent Ethyl More therapies…

    Learn about Your Condition

    Skin neoplasm excision Pharyngeal cancer stage II Cystic fibrosis lung Inner ear disorder Metastatic gastric cancer Papillary thyroid cancer Hypoxia Primary hyperoxaluria Renal disorder Pleomorphic liposarcoma Haemophilia Eyelid ptosis Glomerulonephritis Epidermolysis bullosa Noonan syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier De Versailles

Centre Hospitalier De Versailles

177 Rue De Versailles, Le Chesnay, Le Chesnay-Rocquencourt, 78150, France

Want to learn more about this study or check if you can participate? Contact us.

  • Comparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Etoposide
    • Dexamethasone Acetate
    France

  • A study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Amikacin
    France

  • Methoxyflurane Compared to Morphine for Pain Relief in Patients with Acute Myocardial Infarction Before Hospital Admission

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • MORPHINE
    France

  • Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Caspofungin
    • Fluconazole
    • Anidulafungin
    France

  • Comparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciprofloxacin Hydrochloride
    • Ciprofloxacin
    • Clavulanic Acid
    France

  • Study on Methoxyflurane for Pain Relief in Patients with Heart Attack

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • MORPHINE
    France

  • Study on Reducing Antipsychotic Dose vs. Maintenance Treatment for Patients with Schizophrenia Using Haloperidol Decanoate, Risperidone, and Amisulpride

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Psychotic behaviour
    • Psychotic disorder
    Investigated Drugs:
    • PIPOTIAZINE
    • Amisulpride
    • Flupentixol Decanoate
    France

  • Study on Etoposide for Patients with Severe Hemophagocytic Lymphohistiocytosis in Intensive Care

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Etoposide
    France

  • Study Comparing Different Antibiotic Treatments for ICU Patients with Hospital-Acquired Sepsis: Focus on Cefepime and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Ceftolozane
    • Meropenem
    • Cefepime Hydrochloride
    France

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    • Carfilzomib
    • Dexamethasone
    Belgium France
Previous Page
1 … 6 7 8 9 10 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!